D J Fink

2.2k total citations
40 papers, 1.7k citations indexed

About

D J Fink is a scholar working on Epidemiology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, D J Fink has authored 40 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 14 papers in Genetics and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in D J Fink's work include Herpesvirus Infections and Treatments (19 papers), Virus-based gene therapy research (14 papers) and Pain Mechanisms and Treatments (9 papers). D J Fink is often cited by papers focused on Herpesvirus Infections and Treatments (19 papers), Virus-based gene therapy research (14 papers) and Pain Mechanisms and Treatments (9 papers). D J Fink collaborates with scholars based in United States, France and United Kingdom. D J Fink's co-authors include Joseph C. Glorioso, Marina Mata, William F. Goins, Neal A. DeLuca, Ramesh Ramakrishnan, Michael Levine, Shuanglin Hao, Darren Wolfe, Pietro Luigi Poliani and James R. Goss and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain and Journal of Virology.

In The Last Decade

D J Fink

40 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D J Fink United States 24 674 664 613 531 368 40 1.7k
Nancy R. Cox United States 28 376 0.6× 443 0.7× 849 1.4× 207 0.4× 460 1.3× 76 2.1k
Pascale Giraudon France 28 280 0.4× 593 0.9× 536 0.9× 352 0.7× 106 0.3× 67 2.1k
Michal Schwartz Israel 31 290 0.4× 394 0.6× 1.4k 2.3× 625 1.2× 187 0.5× 92 3.3k
Richard T. Ambron United States 26 148 0.2× 438 0.7× 685 1.1× 737 1.4× 324 0.9× 61 1.9k
Peggy Marconi Italy 32 1.3k 1.9× 918 1.4× 1.3k 2.1× 413 0.8× 179 0.5× 109 3.1k
Margarita Díaz‐Guerra Spain 21 289 0.4× 190 0.3× 638 1.0× 430 0.8× 108 0.3× 40 1.5k
Rebecca Grant United States 21 1.3k 2.0× 297 0.4× 1.5k 2.4× 304 0.6× 273 0.7× 26 2.5k
Peter C. Dowling United States 26 262 0.4× 743 1.1× 383 0.6× 302 0.6× 109 0.3× 63 2.2k
Paul Le Tissier United Kingdom 27 827 1.2× 196 0.3× 1.3k 2.1× 159 0.3× 173 0.5× 59 2.9k
Henry J. Baker United States 28 391 0.6× 248 0.4× 990 1.6× 171 0.3× 798 2.2× 63 2.0k

Countries citing papers authored by D J Fink

Since Specialization
Citations

This map shows the geographic impact of D J Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D J Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D J Fink more than expected).

Fields of papers citing papers by D J Fink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D J Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D J Fink. The network helps show where D J Fink may publish in the future.

Co-authorship network of co-authors of D J Fink

This figure shows the co-authorship network connecting the top 25 collaborators of D J Fink. A scholar is included among the top collaborators of D J Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D J Fink. D J Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fink, D J. (2024). What is the safe noise exposure level to prevent noise-induced hearing loss?. Journal of Exposure Science & Environmental Epidemiology. 35(1). 124–128. 4 indexed citations
2.
Wang, Shaomeng, et al.. (2011). Vector-mediated expression of erythropoietin improves functional outcome after cervical spinal cord contusion injury. Gene Therapy. 19(9). 907–914. 11 indexed citations
3.
Wolfe, Darren, Marina Mata, & D J Fink. (2009). A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Therapy. 16(4). 455–460. 52 indexed citations
4.
Chattopadhyay, Munmun, Cheryl Walter, Marina Mata, & D J Fink. (2008). Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons. Brain. 132(4). 879–888. 37 indexed citations
5.
Hao, Shijie, Jun Hu, & D J Fink. (2008). Transgene-mediated enkephalin expression attenuates signs of naloxone-precipitated morphine withdrawal in rats with neuropathic pain. Behavioural Brain Research. 197(1). 84–89. 19 indexed citations
6.
Chattopadhyay, Munmun, Marina Mata, James R. Goss, et al.. (2007). Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer. Diabetologia. 50(7). 1550–1558. 31 indexed citations
7.
Hao, Shuanglin, Marina Mata, Joseph C. Glorioso, & D J Fink. (2007). Gene transfer to interfere with TNFα signaling in neuropathic pain. Gene Therapy. 14(13). 1010–1016. 81 indexed citations
9.
Burton, Edward A., Joseph C. Glorioso, & D J Fink. (2003). Gene therapy progress and prospects: Parkinson's disease. Gene Therapy. 10(20). 1721–1727. 59 indexed citations
10.
Fink, D J. (2003). Therapeutic gene transfer with herpes-based vectors: studies in Parkinson's disease and motor nerve regeneration. Experimental Neurology. 184. 19–24. 10 indexed citations
11.
Goss, James R., Marina Mata, William F. Goins, et al.. (2001). Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Therapy. 8(7). 551–556. 133 indexed citations
12.
Fink, D J, Neal A. DeLuca, Masanobu Yamada, Darren Wolfe, & Joseph C. Glorioso. (2000). Design and application of HSV vectors for neuroprotection. Gene Therapy. 7(2). 115–119. 37 indexed citations
14.
Makarova, Olga, F Wu, Bryant Villeponteau, et al.. (1996). Incorporation of nuclear matrix attachment regions into the herpes simplex virus type 1 genome does not induce long-term expression of a foreign gene during latency.. PubMed. 3(9). 829–33. 7 indexed citations
15.
Fink, D J, Neal A. DeLuca, William F. Goins, & Joseph C. Glorioso. (1996). Gene Transfer to Neurons Using Herpes Simplex Virus-Based Vectors. Annual Review of Neuroscience. 19(1). 265–287. 142 indexed citations
16.
17.
Glorioso, Joseph C., Neal A. DeLuca, & D J Fink. (1995). DEVELOPMENT AND APPLICATION OF HERPES SIMPLEX VIRUS VECTORS FOR HUMAN GENE THERAPY. Annual Review of Microbiology. 49(1). 675–710. 144 indexed citations
18.
Mata, Marina, et al.. (1994). Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR.. Genome Research. 3(4). 252–255. 53 indexed citations
19.
Glorioso, Joseph C., et al.. (1992). Development of Herpes Simplex Virus as a Gene Transfer Vector for the Central Nervous System. PubMed. 1 Suppl 1. 133–145. 8 indexed citations
20.
Mata, Marina, Sidney N. Kahn, & D J Fink. (1988). A Direct Electron Microscopic Immunocytochemical Study of IgM Paraproteinemic Neuropathy. Archives of Neurology. 45(6). 693–697. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026